- Home
- VNRX vs APLT Comparison
VNRX vs APLT Comparison
Compare VNRX & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- APLT
- Stock Information
- Founded
- VNRX N/A
- APLT 2016
- Country
- VNRX United States
- APLT United States
- Employees
- VNRX N/A
- APLT N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- VNRX Health Care
- APLT Health Care
- Exchange
- VNRX Nasdaq
- APLT Nasdaq
- Market Cap
- VNRX 52.4M
- APLT 44.0M
- IPO Year
- VNRX N/A
- APLT 2019
- Fundamental
- Price
- VNRX $0.67
- APLT $0.42
- Analyst Decision
- VNRX Strong Buy
- APLT Buy
- Analyst Count
- VNRX 5
- APLT 7
- Target Price
- VNRX $3.88
- APLT $6.10
- AVG Volume (30 Days)
- VNRX 307.2K
- APLT 2.6M
- Earning Date
- VNRX 08-13-2025
- APLT 08-06-2025
- Dividend Yield
- VNRX N/A
- APLT N/A
- EPS Growth
- VNRX N/A
- APLT N/A
- EPS
- VNRX N/A
- APLT N/A
- Revenue
- VNRX $1,308,361.00
- APLT $265,000.00
- Revenue This Year
- VNRX $563.72
- APLT $1,768.13
- Revenue Next Year
- VNRX $160.43
- APLT $292.85
- P/E Ratio
- VNRX N/A
- APLT N/A
- Revenue Growth
- VNRX 64.16
- APLT N/A
- 52 Week Low
- VNRX $0.40
- APLT $0.30
- 52 Week High
- VNRX $0.94
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- VNRX 48.82
- APLT 59.95
- Support Level
- VNRX $0.62
- APLT $0.32
- Resistance Level
- VNRX $0.76
- APLT $0.36
- Average True Range (ATR)
- VNRX 0.08
- APLT 0.04
- MACD
- VNRX -0.02
- APLT 0.01
- Stochastic Oscillator
- VNRX 16.73
- APLT 92.91
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.